Viridian Therapeutics Inc
NASDAQ:VRDN

Watchlist Manager
Viridian Therapeutics Inc Logo
Viridian Therapeutics Inc
NASDAQ:VRDN
Watchlist
Price: 22.48 USD 0.22% Market Closed
Market Cap: 1.7B USD
Have any thoughts about
Viridian Therapeutics Inc?
Write Note

Viridian Therapeutics Inc
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Viridian Therapeutics Inc
EPS (Diluted) Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Viridian Therapeutics Inc
NASDAQ:VRDN
EPS (Diluted)
-$3
CAGR 3-Years
40%
CAGR 5-Years
29%
CAGR 10-Years
35%
Abbvie Inc
NYSE:ABBV
EPS (Diluted)
$2
CAGR 3-Years
-12%
CAGR 5-Years
6%
CAGR 10-Years
2%
Gilead Sciences Inc
NASDAQ:GILD
EPS (Diluted)
$0
CAGR 3-Years
-75%
CAGR 5-Years
-47%
CAGR 10-Years
-34%
Amgen Inc
NASDAQ:AMGN
EPS (Diluted)
$7
CAGR 3-Years
-7%
CAGR 5-Years
-10%
CAGR 10-Years
2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
EPS (Diluted)
-$1
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
2%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
EPS (Diluted)
$40
CAGR 3-Years
-13%
CAGR 5-Years
16%
CAGR 10-Years
30%

See Also

What is Viridian Therapeutics Inc's EPS (Diluted)?
EPS (Diluted)
-3.6 USD

Based on the financial report for Jun 30, 2024, Viridian Therapeutics Inc's EPS (Diluted) amounts to -3.6 USD.

What is Viridian Therapeutics Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
35%

Over the last year, the EPS (Diluted) growth was 22%. The average annual EPS (Diluted) growth rates for Viridian Therapeutics Inc have been 40% over the past three years , 29% over the past five years , and 35% over the past ten years .

Back to Top